Research Studies

The CECiLiA study

Who we are looking for

Age five years and over.

Anyone who has attended a C(E)TR in the past 12 months including autistic people, people with a learning disability (including children, family carers, health education and social care professionals) and C(E)TR panel members.

Information about the study

Care (Education) and Treatment Reviews were started in 2014 to help to get autistic people and people with learning disabilities out of psychiatric hospitals and to prevent their admission to psychiatric hospitals. The CECiLiA study aims to determine whether Care (Education) and Treatment Reviews are helpful for people with learning disabilities and autistic people and their families, and what can be improved. It is a three-year study involving  four stages.

What this study involves 

We are focusing on stage one of the study which involves completing a national, co-designed survey about experiences of Care (Education) and Treatment Reviews either on-line or by paper. For those with communication difficulties the study team will assist using talking mats - which is a visual communication framework that supports people with communication difficulties to express their feelings and views.

How to get involved

If you have any questions about the study, please contact the Research Team using the details below from Monday to Friday between 9.00 and 17.00.

Email: Researchinfo@nsft.nhs.uk

Telephone: 01603 421397

Read more about the study and find out how to take part. You can also visit the study website. You can also contact the study team by email: Cecilia@contacts.bham.ac.uk 

Age 16 +

Duration: Up to one hour

Location: One off online questionnaire and optional test

GLAD stands for the genetic links to anxiety and depression. The study is a project set up to support research exploring risk factors for depression and/or anxiety. 

The GLAD study aims to better understand depression and anxiety to find more effective treatments. It hopes to improve the lives of people experiencing these disorders. 

This study is looking for people who are 16 or over and have at some point in their life experienced anxiety and/or depression. The study is also open to those who have never experienced any mental health disorder. 

GLAD is a national study with its own specialist website. Please remember if you found out about the study from Norfolk and Suffolk NHS Foundation Trust then be sure to put that when asked to 'select the NHS trust, GP, talking therapy service or other healthcare provider'.

Register your interest on the GLAD website

COBALT: COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment

A randomised controlled trial assessing whether adding memantine to cholinesterase inhibitors improves the overall health and functioning of people with Lewy Body or Parkinson's Dementia.

Who can take part:

Inclusion criteria (answers must be yes to take part):

• People with a diagnosis of probable Lewy Body Dementia or probable Parkinson's Dementia
• Aged 55+
• Taking a cholinesterase inhibitor for at least 12 weeks
• Sufficient knowledge of the English language or support to understand the Participant Information Sheet and complete the trial assessments

What it involves: If you are interested in taking part, you will be contacted by a member of our research team who will outline the study for you, answer any questions you may have and check your eligibility. Involvment in the study includes being randomised to receive either memantine or a placebo, completion of a weekly diary, 12 months involvement in the study and regular outcome measures being taken for both participant and their trial partner (caregiver).

How to get involved: Contact us via email at Researchinfo@nsft.nhs.uk or via telephone on 01603 421397 to express interest in taking part.

Age 16 +

Duration: Up to one hour

Location: One off online questionnaire and optional test

GLAD stands for the genetic links to anxiety and depression. The study is a project set up to support research exploring risk factors for depression and/or anxiety. 

The GLAD study aims to better understand depression and anxiety to find more effective treatments. It hopes to improve the lives of people experiencing these disorders. 

This study is looking for people who are 16 or over and have at some point in their life experienced anxiety and/or depression. The study is also open to those who have never experienced any mental health disorder. 

GLAD is a national study with its own specialist website. Please remember if you found out about the study from Norfolk and Suffolk NHS Foundation Trust then be sure to put that when asked to 'select the NHS trust, GP, talking therapy service or other healthcare provider'.

Register your interest on the GLAD website

Looking for: People aged 16 and above who have experienced, or are experiencing any eating disorder and live in England.

Location: Online

Info about the study

What will taking part involve? Taking part in this study will involve completing some questions which will ask about your demographics (e.g. age, gender and employment situation), emotional wellbeing, health and lifestyle, personality and experiences of an eating disorder. Following this you will be sent a kit to take a saliva sample, which you will then need to send back to the study team via pre-paid post.

Please remember if you found out about the study from Norfolk and Suffolk NHS Foundation Trust then be sure to put that when asked to 'select the NHS trust, GP, talking therapy service or other healthcare provider'

Contact the research team

If you have any questions about the study, please contact the research team using the below email address:

Researchinfo@nsft.nhs.uk

Need more information? Willing to take part?

For further information see: https://edgiuk.org/ 

PPIP2 — Prevalence of Pathogenic Antibodies in Psychosis

Looking for: 

Individuals between the age of 16-70 years who are experiencing a current episode of psychosis lasting less than 2 years. This can be a first episode or relapse.

Information about the study

The aim is to assess the number of patients experiencing psychosis that also have anti-neuronal membrane antibodies which might cause their illness.

What will taking part involve:

• One-off visit.
• Questionnaires regarding demographic information, previous history of psychotic illness and length of current episode of psychosis symptoms.
• Blood sample.

Contact the research team

If you have any questions about the study, please contact the research team using the details below (Mon-Fri 9am to 5pm)

Email: Researchinfo@nsft.nhs.uk

Telephone: 01603 421397

Need more information? Willing to take part?

For further information visit the national website and choose Norfolk & Suffolk NHS Foundation Trust

Age 16 +

Duration: Up to one hour

Location: One off online questionnaire and optional test

GLAD stands for the genetic links to anxiety and depression. The study is a project set up to support research exploring risk factors for depression and/or anxiety. 

The GLAD study aims to better understand depression and anxiety to find more effective treatments. It hopes to improve the lives of people experiencing these disorders. 

This study is looking for people who are 16 or over and have at some point in their life experienced anxiety and/or depression. The study is also open to those who have never experienced any mental health disorder. 

GLAD is a national study with its own specialist website. Please remember if you found out about the study from Norfolk and Suffolk NHS Foundation Trust then be sure to put that when asked to 'select the NHS trust, GP, talking therapy service or other healthcare provider'.

Register your interest on the GLAD website